Karpas Strategies, LLC has filed its 13F form on July 30, 2024 for Q2 2024 where it was disclosed a total value porftolio of $262 Million distributed in 117 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Johnson & Johnson with a value of $19M, Schwab Charles Corp with a value of $18.5M, Merck & Co., Inc. with a value of $16.5M, Oneok Inc with a value of $15.8M, and Berkshire Hathaway Inc Class B with a value of $10.2M.

Examining the 13F form we can see an decrease of $1.95M in the current position value, from $264M to 262M.

Below you can find more details about Karpas Strategies, LLC portfolio as well as his latest detailed transactions.

Portfolio value $262 Million
Financial Services: $76.8 Million
Healthcare: $45.1 Million
Energy: $40.7 Million
Technology: $26.2 Million
Communication Services: $20.4 Million
Utilities: $17.1 Million
Real Estate: $9.45 Million
ETFs: $8.42 Million
Other: $17.6 Million

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 117
  • Current Value $262 Million
  • Prior Value $264 Million
  • Filing
  • Period Q2 2024
  • Filing Date July 30, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 3 stocks
  • Additional Purchases 48 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 34 stocks
Track This Portfolio

Track Karpas Strategies, LLC Portfolio

Follow Karpas Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Karpas Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Karpas Strategies, LLC with notifications on news.